Black Rock Inc. Unity Biotechnology, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.4 - $4.27 $6,730 - $71,842	-16,825 Reduced 2.9%	563,488 $223,000
Q2 2022 Aug 12, 2022	BUY	$0.56 - $1.29 $5,580 - $12,856	9,966 Added 1.75%	580,313 $327,000
Q1 2022 May 12, 2022	SELL	$0.72 - $1.86 $3,726 - $9,625	-5,175 Reduced 0.9%	570,347 $638,000
Q4 2021 Feb 10, 2022	SELL	$1.3 - $3.17 $422,640 - $1.03 Million	-325,108 Reduced 36.1%	575,522 $840,000
Q3 2021 Nov 09, 2021	BUY	$2.91 - $4.5 $52,551 - $81,265	18,059 Added 2.05%	900,630 $2.7 Million
Q2 2021 Aug 11, 2021	BUY	$4.15 - $6.3 $3.66 Million - $5.56 Million	882,571 New	882,571 $4.09 Million

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.